Carmine Carbone

3.7k total citations
84 papers, 2.3k citations indexed

About

Carmine Carbone is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Carmine Carbone has authored 84 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Oncology, 33 papers in Molecular Biology and 21 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Carmine Carbone's work include Pancreatic and Hepatic Oncology Research (27 papers), Cancer Immunotherapy and Biomarkers (10 papers) and Lung Cancer Treatments and Mutations (6 papers). Carmine Carbone is often cited by papers focused on Pancreatic and Hepatic Oncology Research (27 papers), Cancer Immunotherapy and Biomarkers (10 papers) and Lung Cancer Treatments and Mutations (6 papers). Carmine Carbone collaborates with scholars based in Italy, United States and Japan. Carmine Carbone's co-authors include Davide Melisi, Geny Piro, Giampaolo Tortora, Alfredo Budillon, Raffaela Santoro, Elena Di Gennaro, Paul J. Chiao, Valeria Merz, Francesca Simionato and Anna Tamburrino and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Carmine Carbone

79 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carmine Carbone Italy 29 1.2k 911 537 385 354 84 2.3k
Germana Castelli Italy 29 1.6k 1.4× 798 0.9× 950 1.8× 478 1.2× 400 1.1× 97 3.1k
Chao Ni China 32 1.3k 1.1× 960 1.1× 915 1.7× 343 0.9× 642 1.8× 95 2.9k
Alexey V. Sorokin United States 22 1.3k 1.1× 679 0.7× 353 0.7× 222 0.6× 164 0.5× 53 2.2k
Jing Jiang United States 29 846 0.7× 594 0.7× 325 0.6× 457 1.2× 214 0.6× 62 2.1k
Carolin Mogler Germany 29 1.1k 0.9× 656 0.7× 436 0.8× 309 0.8× 397 1.1× 126 2.7k
Michael K. Wong United States 26 701 0.6× 1.1k 1.2× 246 0.5× 415 1.1× 336 0.9× 100 2.2k
Tao Tian China 26 1.0k 0.9× 499 0.5× 645 1.2× 296 0.8× 189 0.5× 107 2.0k
Guoping Wang China 24 977 0.8× 419 0.5× 361 0.7× 280 0.7× 207 0.6× 87 1.9k
Jian Xu China 32 1.8k 1.5× 420 0.5× 888 1.7× 317 0.8× 472 1.3× 112 3.0k

Countries citing papers authored by Carmine Carbone

Since Specialization
Citations

This map shows the geographic impact of Carmine Carbone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carmine Carbone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carmine Carbone more than expected).

Fields of papers citing papers by Carmine Carbone

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carmine Carbone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carmine Carbone. The network helps show where Carmine Carbone may publish in the future.

Co-authorship network of co-authors of Carmine Carbone

This figure shows the co-authorship network connecting the top 25 collaborators of Carmine Carbone. A scholar is included among the top collaborators of Carmine Carbone based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carmine Carbone. Carmine Carbone is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Carbone, Carmine, R. De Luca, Emanuele Puca, et al.. (2025). Antibody-based delivery of interleukin-2 modulates the immunosuppressive tumor microenvironment and achieves cure in pancreatic ductal adenocarcinoma syngeneic mice. Journal of Experimental & Clinical Cancer Research. 44(1). 7–7. 1 indexed citations
3.
4.
Chiaravalli, Marta, et al.. (2022). Immunogenic Cell Death: An Emerging Target in Gastrointestinal Cancers. Cells. 11(19). 3033–3033. 34 indexed citations
5.
Luigetti, Marco, Ângela Romano, Valeria Guglielmino, et al.. (2022). Serum Inflammatory Profile in Hereditary Transthyretin Amyloidosis: Mechanisms and Possible Therapeutic Implications. Brain Sciences. 12(12). 1708–1708. 5 indexed citations
6.
Cencioni, Chiara, Ilaria Trestini, Geny Piro, et al.. (2022). Gastrointestinal Cancer Patient Nutritional Management: From Specific Needs to Novel Epigenetic Dietary Approaches. Nutrients. 14(8). 1542–1542. 25 indexed citations
7.
Piro, Geny, Carmine Carbone, Antonio Agostini, et al.. (2022). CXCR1/2 dual-inhibitor ladarixin reduces tumour burden and promotes immunotherapy response in pancreatic cancer. British Journal of Cancer. 128(2). 331–341. 19 indexed citations
8.
Carbone, Carmine, Geny Piro, Antonio Agostini, et al.. (2021). Intratumoral injection of TLR9 agonist promotes an immunopermissive microenvironment transition and causes cooperative antitumor activity in combination with anti-PD1 in pancreatic cancer. Journal for ImmunoTherapy of Cancer. 9(9). e002876–e002876. 49 indexed citations
9.
Cammarota, Giovanni, Gianluca Ianiro, Carmine Carbone, et al.. (2020). Gut microbiome, big data and machine learning to promote precision medicine for cancer. Nature Reviews Gastroenterology & Hepatology. 17(10). 635–648. 215 indexed citations
10.
Park, Shin‐Young, Alessandro Mattè, Yookyung Jung, et al.. (2020). Pathologic angiogenesis in the bone marrow of humanized sickle cell mice is reversed by blood transfusion. Blood. 135(23). 2071–2084. 46 indexed citations
11.
Piro, Geny, Carmine Carbone, Luisa Carbognin, et al.. (2019). Revising PTEN in the Era of Immunotherapy: New Perspectives for an Old Story. Cancers. 11(10). 1525–1525. 30 indexed citations
12.
Γκουντάκος, Αναστάσιος, Giulia Sartori, Italia Falcone, et al.. (2019). PTEN in Lung Cancer: Dealing with the Problem, Building on New Knowledge and Turning the Game Around. Cancers. 11(8). 1141–1141. 83 indexed citations
13.
Filippini, Dea, Pietro Delfino, Michele Simbolo, et al.. (2019). Immunoevolution of mouse pancreatic organoid isografts from preinvasive to metastatic disease. Scientific Reports. 9(1). 12286–12286. 24 indexed citations
14.
Carbone, Carmine, Geny Piro, Vincenzo Di Noia, et al.. (2019). Lung and Gut Microbiota as Potential Hidden Driver of Immunotherapy Efficacy in Lung Cancer. Mediators of Inflammation. 2019. 1–10. 43 indexed citations
15.
Carbone, Carmine, Geny Piro, Valeria Merz, et al.. (2018). Angiopoietin-Like Proteins in Angiogenesis, Inflammation and Cancer. International Journal of Molecular Sciences. 19(2). 431–431. 161 indexed citations
16.
Piro, Geny, Carmine Carbone, Raffaela Santoro, Giampaolo Tortora, & Davide Melisi. (2018). Predictive biomarkers for the treatment of resectable esophageal and esophago-gastric junction adenocarcinoma: from hypothesis generation to clinical validation. Expert Review of Molecular Diagnostics. 18(4). 357–370. 4 indexed citations
17.
Cascetta, Priscilla, Alessandro Cavaliere, Geny Piro, et al.. (2018). Pancreatic Cancer and Obesity: Molecular Mechanisms of Cell Transformation and Chemoresistance. International Journal of Molecular Sciences. 19(11). 3331–3331. 40 indexed citations
18.
Carbone, Carmine, Geny Piro, Francesca Simionato, et al.. (2017). Homeobox B9 Mediates Resistance to Anti-VEGF Therapy in Colorectal Cancer Patients. Clinical Cancer Research. 23(15). 4312–4322. 41 indexed citations
19.
Melisi, Davide, Melissa Frizziero, Anna Tamburrino, et al.. (2014). Toll-Like Receptor 9 Agonists for Cancer Therapy. Biomedicines. 2(3). 211–228. 32 indexed citations
20.
Carbone, Carmine, Tania Moccia, Cihui Zhu, et al.. (2011). Anti-VEGF Treatment–Resistant Pancreatic Cancers Secrete Proinflammatory Factors That Contribute to Malignant Progression by Inducing an EMT Cell Phenotype. Clinical Cancer Research. 17(17). 5822–5832. 80 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Germana Castelli Breakdown of academic impact, for papers by Chao Ni Breakdown of academic impact, for papers by Alexey V. Sorokin Breakdown of academic impact, for papers by Jing Jiang Breakdown of academic impact, for papers by Carolin Mogler Breakdown of academic impact, for papers by Michael K. Wong Breakdown of academic impact, for papers by Tao Tian Breakdown of academic impact, for papers by Guoping Wang Breakdown of academic impact, for papers by Jian Xu
Rankless by CCL
2026